EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy

Hyun Jung Lee, Ji Wook Moon, Seong-Joon Koh, Jong Pil Im, Byeong Gwan Kim, Joo Sung Kim

Scientific Reports · 2024

DOI: 10.1038/s41598-024-78581-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Hyun Jung Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, …. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Non-Steroidal, Apoptosis, Indomethacin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: SNUH Research Fund, Korean government (MSIT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the non-steroidal anti-inflammatory drugs (NSAIDs) are typically used in the treatment of chronic conditions, the incidence of NSAID-induced enteropathy is increasing. Given the challenges associated with discontinuing NSAIDs, effective preventive and treatment strategies are crucial. We assessed the effect of tegoprazan on NSAID-induced enteropathy. Human epithelial cells (HIEC-6, HT-29, and Caco-2) were treated with indomethacin and tegoprazan. Cell viability, expression levels of tight-junction proteins, levels of proinflammatory cytokines, and apoptosis were assessed by conducting MTT assays, RT-PCR, western blotting, and immunofluorescence staining, respectively. Tegoprazan significantly ameliorated the inhibition of cell proliferation induced by indomethacin. Tegoprazan also mitigated the suppression of occludin and ZO-1 expression by indomethacin, thereby restoring intestinal permeability. Additionally, tegoprazan reversed the indomethacin-induced elevation of the levels of proinflammatory cytokines and the rate of apoptosis of small intestinal epithelial cells. Our findings indicate that tegoprazan exerts a protective effect against NSAID-induced injury to small intestinal epithelial cells. The effect involves enhancement of the expression levels of tight junction proteins and the suppression of inflammation and apoptosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalApoptosisIndomethacinHumansCaco-2 CellsCell ProliferationHT29 CellsCell SurvivalEpithelial CellsIntestinal MucosaCytokinesIntestinal DiseasesCell LineTight Junction Proteins

Stichwörter der Autor:innen

EnteropathyNon-steroidal anti-inflammatory drugPermeabilityTegoprazan

Substanzen

Anti-Inflammatory Agents, Non-SteroidalIndomethacinCytokinesTight Junction Proteins

Autor:innen und Institutionen

  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea. guswjd80@snu.ac.kr.
  • BK21 Graduate Program, Department of Biomedical Sciences, Department of Anatomy, Korea University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.

Förderung

  • SNUH Research Fund
  • Korean government (MSIT)

Zitieren

APA

Lee, H. J., Moon, J. W., Koh, S. J., Im, J. P., Kim, B. G., & Kim, J. S. (2024). Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy. Scientific Reports. https://doi.org/10.1038/s41598-024-78581-2

Vancouver

Lee HJ, Moon JW, Koh SJ, Im JP, Kim BG, Kim JS. Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy. Scientific Reports. 2024. doi:10.1038/s41598-024-78581-2

BibTeX
@article{Lee2024,
  author = {Lee, Hyun Jung and Moon, Ji Wook and Koh, Seong-Joon and Im, Jong Pil and Kim, Byeong Gwan and Kim, Joo Sung},
  title = {Effect of tegoprazan, a novel potassium-competitive acid blocker, on non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy},
  journal = {Scientific Reports},
  year = {2024},
  doi = {10.1038/s41598-024-78581-2}
}
Kostenlos starten →